Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.
Quanta Therapeutics has raised $50.7M in total funding. The most recent round was Series D. The last funding was announced in May 2023.
Quanta Therapeutics's investors include AbbVie, Longitude Capital, Vida Ventures, Sofinnova Investments, Avidity Partners.
Quanta Therapeutics is headquartered in San Francisco, United States.
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.
Quanta Therapeutics is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Quanta Therapeutics — Funding & Investors." VCBacked, May 22, 2023, https://www.vcbacked.co/company/quanta-therapeutics. Accessed October 2, 2026.
VCBacked. (2023). Quanta Therapeutics — Funding & Investors. Retrieved October 2, 2026, from https://www.vcbacked.co/company/quanta-therapeutics
{{cite web |title=Quanta Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/quanta-therapeutics |website=VCBacked |access-date=October 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated